Emergent BioSolutions: Clinical Trials

64 trials sponsored by Emergent BioSolutions, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

52 completed, 5 not yet recruiting, 5 terminated, 2 enrolling by invitation. 23 Phase 1, 15 Phase 2, 12 Phase 3, 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 123Completed 20, Terminated 3
Phase 215Completed 14, Terminated 1
Phase 312Completed 11, Terminated 1
Phase 45Completed 3, Enrolling by invitation 1, Not yet recruiting 1

Follow Emergent BioSolutions: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease.
CYFENDUS - Anthrax
Not yet recruitingEmergent BioSolutions2502035-11-012025-12-08
A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients
AIGIV - Inhalational Anthrax
Not yet recruitingEmergent BioSolutions1002027-05-302026-02-06
Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax
Collection of samples - Infections, Bacterial
Not yet recruitingEmergent BioSolutions102027-05-012026-03-17
Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario
Sample Collection - Infections, Bacterial
Phase 4Not yet recruitingEmergent BioSolutions1002027-01-012026-02-06
Observational Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Patients With Systemic Anthrax
AIGIV - Anthrax
Not yet recruitingEmergent BioSolutions102026-11-302026-02-06
Study Evaluating the Bioequivalence of Brincidofovir Form H and Form II Tablets in Healthy Adults
Brincidofovir - Smallpox
Phase 1CompletedEmergent BioSolutions442023-05-302025-01-15
Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years
CHIKV VLP/adjuvant, Placebo - Chikungunya Virus
Phase 3CompletedBavarian Nordic4132022-05-122024-12-13
Pharmacokinetics (PK) and Safety of Multiple Doses of Intranasal Naloxone in Healthy Adults
16 mg naloxone AP003, 8 mg naloxone NARCAN Nasal Spray - Opioid Overdose
Phase 1CompletedEmergent BioSolutions242022-03-282026-08-19
Study of SIAN Nasal Spray in Healthy Adults
Stabilized Isoamyl Nitrite (SIAN) - Cyanide Poisoning
Phase 1CompletedEmergent BioSolutions472021-12-212025-06-03
A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes to SARS-CoV-2 Uninfected Adults
COVID-HIG - SARS-CoV-2 Infection
Phase 1CompletedEmergent BioSolutions232021-12-072025-06-08
Universal Influenza A Vaccine in Healthy Adults
UFluA 20 µg each antigen/dose, UFluA 60 µg each antigen/dose, Placebo - Human Influenza
Phase 1CompletedEmergent BioSolutions272021-12-012025-01-20
A Study to Assess the Safety and Immunogenicity of PXVX0317 Chikungunya Virus Virus-Like Particle Vaccine
CHIKV VLP, adjuvanted - Chikungunya Virus
Phase 2CompletedBavarian Nordic252021-10-112023-07-03
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine)
CHIKV VLP/adjuvant, Placebo - Chikungunya Virus
Phase 3CompletedBavarian Nordic32582021-09-292024-08-30
A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy Adults
COVID-HIGIV, Placebo (saline) - COVID-19
Phase 1CompletedEmergent BioSolutions282020-12-242025-06-08
Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317)
Chikungunya - Chikungunya
Phase 2CompletedBavarian Nordic602019-11-202024-10-16
Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study
Ciprofloxacin 500Mg Tablet, Doxycycline 100Mg Tablet, AV7909 - Anthrax
Phase 2CompletedEmergent BioSolutions2102019-08-122025-09-08
VELOCITY: An Anthrax Vaccine Clinical Study
AV7909, BioThrax - Anthrax
Phase 3CompletedEmergent BioSolutions36892019-03-112026-05-06
Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG)
Zika Virus Immune Globulin (ZIKV-IG), Placebo - Zika Virus Infection, Zika Virus Disease
Phase 1CompletedEmergent BioSolutions302018-06-272024-03-18
Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults
CHIKV VLP/unadjuvanted, CHIKV VLP/adjuvanted, Placebo - Chikungunya Virus Infection
Phase 2CompletedBavarian Nordic4452018-04-182023-07-03
Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika Virus Vaccine Candidate in Healthy Adults
VLA1601, Placebo - Zika Virus, Zika Virus Infection
Phase 1CompletedValneva Austria GmbH672018-02-242019-07-05

Showing 20 of 64. Sign in to see all of them.

Conditions studied

Anthrax (14)  ·  Smallpox (7)  ·  Cholera (6)  ·  Bacterial Infections (5)  ·  Chikungunya Fever (4)  ·  Vaccinia (4)  ·  Influenza, Human (3)  ·  Inhalation anthrax (3)  ·  Virus Diseases (3)  ·  Arbovirus Infections (2)  ·  Botulism (2)  ·  COVID-19 (2)  ·  Dengue (2)  ·  Flaviviridae Infections (2)  ·  Flavivirus Infections (2)

Interventions

Biothrax (6)  ·  Anthrax Vaccines (5)  ·  ACAM2000 (4)  ·  Anthrax Immune Globulin Intravenous (3)  ·  raxibacumab (3)  ·  Botulinum Antitoxin (2)  ·  Ciprofloxacin (2)  ·  Smallpox Vaccine (2)  ·  AERAS-402 (1)  ·  AIDSVAX B-E (1)  ·  AVP-21D9 (1)  ·  Cholera Vaccines (1)  ·  Diphenhydramine (1)  ·  Doxycycline (1)  ·  DryVax vaccine (1)

Countries

United States (47)  ·  Canada (3)  ·  Australia (2)  ·  Mali (1)  ·  Puerto Rico (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

James McCarty, MD (5)  ·  Bojan Drobic, PhD (2)  ·  Brandon Essink, MD (2)  ·  Gideon Akintunde, MD (2)  ·  Patrick Ajiboye, MD (2)  ·  Robert Hopkins, MD, MPH, TM (2)  ·  Ronald Brown, MD (2)  ·  Abhay Patki, PhD (1)  ·  Alan S Marion, MD, PhD (1)  ·  Bojan Drobic (1)  ·  Chris Cabell, MD, MHS (1)  ·  Christine Hall (1)  ·  Christine Hall, PhD (1)

Results publications

PMID 35709798, PMID 19587338, PMID 20188175, PMID 23369412, PMID 23701746, PMID 23979731, PMID 24173028, PMID 24733473, PMID 26529238, PMID 27001804, PMID 28566334, PMID 29021299, PMID 29317118, PMID 29624592, PMID 29655627, PMID 30772070, PMID 31209461, PMID 31743334, PMID 31769402, PMID 32333847, PMID 32967791, PMID 34454787, PMID 34610572, PMID 35939501, PMID 36852998, PMID 37376480, PMID 38352727, PMID 39004524, PMID 39954701, PMID 40158524, PMID 40158526, PMID 41401704, PMID 41447782, PMID 42332351